drugset / Trial / NCT06713837

Summary

This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reinduction chemotherapy with low intensity therapies in 1st or 2nd relapse Acute Myeloid Leukemia. The study is funded by European Commission (HORIZON-MISS-2022-CANCER-01-03, Project ID 101104421)

Timeline

Start
2025-02-27
Primary completion
2028-01
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azacitidine Other / unclassified
Comparator Cladribine Small molecule 5 mg/m2
Comparator Cytarabine Small molecule
Comparator Daunorubicin Small molecule
Subject Decitabine Small molecule
Comparator Etoposide Small molecule
Comparator Fludarabine Small molecule
Subject Gemtuzumab Monoclonal antibody
Subject Gilteritinib Small molecule
Subject Glasdegib Small molecule
Comparator Idarubicin Small molecule
Subject Ivosidenib Small molecule
Comparator Mitoxantrone Small molecule
Subject Venetoclax Small molecule